Physician profile
Katherine B Mitchell
NPI 1871575886
$1,429.63
in general payments reported to CMS, 2019-2025
19 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $273 · 2021: $313 · 2022: $88.93 · 2023: $88.36 · 2024: $120 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $212.85 | 2019-2021 | |
| Amgen INC. | $178.36 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $150.06 | 2019 | |
| Abbvie INC. | $149.47 | 2021-2022 | |
| Kite Pharma, INC. | $100.61 | 2025 | |
| Beigene USA, INC. | $99.97 | 2024 | Brukinsa |
| Allergan, INC. | $99.26 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $91.43 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $88.36 | 2023 | Onureg |
| Astellas Pharma US INC | $72.61 | 2019-2020 | |
| Glaxosmithkline, LLC. | $34.81 | 2019-2021 | |
| Pfizer INC. | $31.26 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.26 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $27.13 | 2021 | |
| Amarin Pharma, INC. | $16.49 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.35 | 2019 | |
| Horizon Therapeutics Plc | $12.88 | 2020 | |
| Antares Pharma, INC. | $11.60 | 2020 | |
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.